Adherence to higher Life’s Essential 8 scores is linearly associated with reduced all-cause and cardiovascular mortality among US adults with metabolic syndrome: Results from NHANES 2005–2018
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0314152 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Dao-Cheng Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardiovascular Diseases, Nutrition Surveys. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Healthcare Engineering SanMing Program, Shenzhen Baoan Science and Technology Programme Project of Medical and Health Research Program, Guangdong Basic and Applied Basic Research Fund Enterprise Joint Fund Program.
Abstract (Originalsprache)
Background
Life’s Essential 8 (LE8) is the American Heart Association (AHA)’s recently updated assessment of cardiovascular health (CVH). Metabolic syndrome (MetS) is one of the most common chronic noncommunicable diseases associated with CVH impairment and an increased risk of mortality. However, the association of LE8 with all-cause and disease-specific mortality in the MetS population remains unknown. We aimed to explore these associations in a national prospective cohort study from NHANES 2005–2018.
Methods
The LE8 was calculated according to the assessment criteria proposed by the AHA, which includes health behavior and health factor domains. LE8 scores were categorized as low CVH (0–49), moderate CVH (50–79), and high CVH (80–100). MetS was assessed according to NCEP-ATP III criteria, and mortality data were obtained through prospective linkage to the National Death Index database.
Results
7839 participants with MetS were included and only 3.5% were in high CVH. In the fully adjusted models, LE8 was negatively associated with both all-cause and cardiovascular disease (CVD) mortality (hazard ratios [HR] and 95% confidence intervals [CI] of 0.978 (0.971,0.984) and 0.972 (0.961,0.984), respectively, both p < 0.0001). Both moderate/high CVH were associated with significantly lower mortality compared to low CVH (both p for trend
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong, China.
- The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
- Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
ORCID-Profile: Hui-Lin Li
Förderung
- Shenzhen Healthcare Engineering SanMing Program
- Shenzhen Baoan Science and Technology Programme Project of Medical and Health Research Program
- Guangdong Basic and Applied Basic Research Fund Enterprise Joint Fund Program
- Guangdong Provincial Bureau of Traditional Chinese Medicine Scientific Research Programme
- Shenzhen Hospital of Traditional Chinese Medicine Intramural Programme
Zitieren
APA
Zhou, D. C., Liang, J. L., Hu, X. Y., Fang, H. C., Liu, D. L., Zhao, H. X., Li, H. L., & Xu, W. H. (2024). Adherence to higher Life’s Essential 8 scores is linearly associated with reduced all-cause and cardiovascular mortality among US adults with metabolic syndrome: Results from NHANES 2005–2018. PLOS ONE. https://doi.org/10.1371/journal.pone.0314152
Vancouver
Zhou DC, Liang JL, Hu XY, Fang HC, Liu DL, Zhao HX, et al. Adherence to higher Life’s Essential 8 scores is linearly associated with reduced all-cause and cardiovascular mortality among US adults with metabolic syndrome: Results from NHANES 2005–2018. PLOS ONE. 2024. doi:10.1371/journal.pone.0314152
BibTeX
@article{Zhou2024,
author = {Zhou, Dao-Cheng and Liang, Jia-Lin and Hu, Xin-Yu and Fang, Hong-Cheng and Liu, De-Liang and Zhao, Heng-Xia and Li, Hui-Lin and Xu, Wen-Hua},
title = {Adherence to higher Life’s Essential 8 scores is linearly associated with reduced all-cause and cardiovascular mortality among US adults with metabolic syndrome: Results from NHANES 2005–2018},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0314152}
}
EUVIMED